Abstract:Introduction: diabetes is a metabolic disease characterized by chronic hyperglycemia. The latter plays an essential role in inflammation by stimulating the production of pro-inflammatory cytokines or by increasing their secretion by an oxidative mechanism. These cytokines control the hepatic synthesis of an inflammatory protein called C-Reactive Protein (CRP). Thus, CRP could serve as a biomarker of risk of onset, monitoring and prognosis for type 2 diabetes. To answer this problem, we conducted this study, the purpose of which was to determine the predictive role of hsCRP in the risk of type 2 diabetes mellitus and its cardiovascular complications. Methodology: this is a prospective and cross-sectional case-control study involving 200 participants including 100 control women and 100 women with type 2 diabetes (mean age was respectively 49.89 years ± 8.26 & 51.92 years ± 7.18 ; p=0.066). The interviews were conducted on the basis of a questionnaire. Physical examination collected biometrics data and cardiovascular constants. The biochemical parameters were analyzed by an automated Abbott device. Results: we found, in control women, a positive correlation between hsCRP and BMI (rho=0.40 p<0.0001), waist-to-hip ratio (rho=0.24 p<0.0001), systolic blood pressure (rho=0.30 p=0.003), diastolic blood pressure (rho=0.28 p=0.006), total body fat (rho=0.48 p<0.0001), visceral fat level (rho=0.47 p<0.0001), glycated hemoglobin (rho=0.29 p=0.003), fasting insulin (rho=0.22 p=0.026), C-peptide level (rho=0.35 p=0.0003), to HOMA-IR (rho=0.21 p=0.034), total cholesterol (rho=0.24 p=0.016), HDL cholesterol (rho=0.24 p=0.019), apolipoprotein B level (rho=0.25 p=0.013). At the same time, hsCRP was negatively correlated with adiponectin level (rho=-0.21 p=0.04) and the nitric oxide level (rho=-0.26 p=0.01). In contrast, in women with type 2 diabetes, hsCRP was positively associated with BMI (rho=0.38 p=0.007), WHR (rho=0.43 p=0.002), total body fat (rho=0.25 p=0.014), heart rate (rho=0.34 p=0.001) and glycated hemoglobin (rho=0.21 p=0.036). Conclusion: hsCRP has a prognostic value in the evaluation of cardiovascular risk. It seems to play an important role in the pathogenesis of type 2 diabetes mellitus and its cardiovascular complications. It could thus be considered as a biomarker for the screening, monitoring and prognosis of type 2 diabetes mellitus.

Description Of C-Reactive Protein (CRP) In Patients With Type 2 Diabetes Mellitus At Mulyorejo Health Center In Malang City

Serum N-3 Polyunsaturated Fatty Acid and High-sensitivity C Reactive Protein in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Change of High Sensitive CRP and WBC Count in Coronary Heart Disease Patients with Type 2 Diabetes

Positive Association Between High-Sensitivity C-Reactive Protein and Incidence of Type 2 Diabetes Mellitus in Japanese Workers: 6-Year Follow-Up

C-reactive Protein for Predicting Cardiovascular and All-Cause Mortality in Type 2 Diabetic Patients: A Meta-Analysis

Diabetes and Inflammation; Association Between C-Reactive Protein and Diabetic Nephropathy in Rawalpindi

Relationship of Serum C Reactive Protein Level with Serum Leptin Concentration in Type 2 Diabetic Patients

Risk of Cardiovascular Complication Among Type 2 Diabetes Mellitus Patients in Medan, Indonesia. A Cross-sectional Study

Clinical Significance of Determination of Serum Cystatin C,lipoprotein (α) and High Sensitivity C-reactive Protein in Type 2 Diabetic Patients with Early Renal Impairment.

Association Between High-Sensitivity C-Reactive Protein and Diabetic Kidney Disease in Patients With Type 2 Diabetes Mellitus

Contribution of High Sensible Crp (Hscrp) in the Assessment of the Risk of Onset of Type 2 Diabetes and its Cardiovascular Complications

The Relationship Between C-reactive Protein and Glycemic Control in Short Duration Diabetic Patients

Correlationship Between High Sensitive C -Reactive Protein and Interleukin -6 in Patients with Type 2 Diabetes Mellitus Complicated with Coronary Artery Disease

Effects of glucose control on the levels of C reactive protein and interleukin-6 in patients with newly onset type 2 diabetics

Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control

Association of Serum Phospholipid Fatty Acid and High-Sensitivity C Reactive Protein in Patients with Metabolic Syndrome and Type 2 Diabetes Mellitus

Influence of Metformin on C-reactive Protein in Patients with Type 2 Diabetes Mellitus

Survey of the Levels, Relationship Between Resistin and C Reactive-Protein in Diabetics

A STUDY OF SERUM URIC ACID LEVELS IN TYPE 2 DIABETES MELLITUS CASES AND ITS COMPARISON WITH THE SERUM CREATININE LEVELS

Gambaran Kadar Glukosa Darah Puasa dan D-dimer pada Pasien Diabetes Tipe 2 Terkontrol

Associations of Insulin Resistance and High-Sensitivity C-Reactive Protein with Metabolic Abnormalities in Korean Patients with Type 2 Diabetes Mellitus: A Preliminary Study